
Acquisition Announcement Sparks Buying Spree For This Micro Cap
Seeing that the company closed Tuesday’s session with a market cap of around $53 million, it’s no wonder that traders rushed to snatch up shares of %iCad Inc. (Nasdaq: $ICAD) following the announcement, with traders currently bid for the micro cap at $3.23/share (+67.36% implied open for sellers) at the time of writing. Keep an eye on this one!
icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment